company background image
690 logo

Uni-Bio Science Group SEHK:690 Stock Report

Last Price

HK$0.062

Market Cap

HK$364.2m

7D

-1.6%

1Y

-31.1%

Updated

07 Feb, 2025

Data

Company Financials

Uni-Bio Science Group Limited

SEHK:690 Stock Report

Market Cap: HK$364.2m

690 Stock Overview

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China. More details

690 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Uni-Bio Science Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Uni-Bio Science Group
Historical stock prices
Current Share PriceHK$0.062
52 Week HighHK$0.098
52 Week LowHK$0.046
Beta-0.095
1 Month Change-1.59%
3 Month Change1.64%
1 Year Change-31.11%
3 Year Change-37.37%
5 Year Change-59.48%
Change since IPO-87.23%

Recent News & Updates

Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Dec 11
Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement

Sep 13
Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement

Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive

Jul 29
Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive

Recent updates

Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Dec 11
Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement

Sep 13
Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement

Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive

Jul 29
Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive

Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 27% Dive

May 27
Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 27% Dive

Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Apr 24
Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?

Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Jan 22
Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%

Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Oct 24
Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement

Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)

Apr 30
Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)

We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Nov 22
We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)

Jan 05
Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)

Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth

Mar 01
Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth

Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years

Jan 05
Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years

We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Nov 23
We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow

Shareholder Returns

690HK BiotechsHK Market
7D-1.6%4.5%2.3%
1Y-31.1%14.6%24.5%

Return vs Industry: 690 underperformed the Hong Kong Biotechs industry which returned 14.6% over the past year.

Return vs Market: 690 underperformed the Hong Kong Market which returned 24.5% over the past year.

Price Volatility

Is 690's price volatile compared to industry and market?
690 volatility
690 Average Weekly Movement6.3%
Biotechs Industry Average Movement7.9%
Market Average Movement6.4%
10% most volatile stocks in HK Market13.7%
10% least volatile stocks in HK Market3.0%

Stable Share Price: 690 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 690's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001458Frank Zhaowww.uni-bioscience.com

Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China. It operates in Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Boshutai, a small molecule drug to treat diabetes.

Uni-Bio Science Group Limited Fundamentals Summary

How do Uni-Bio Science Group's earnings and revenue compare to its market cap?
690 fundamental statistics
Market capHK$364.24m
Earnings (TTM)HK$98.86m
Revenue (TTM)HK$508.40m

3.7x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
690 income statement (TTM)
RevenueHK$508.40m
Cost of RevenueHK$83.85m
Gross ProfitHK$424.55m
Other ExpensesHK$325.70m
EarningsHK$98.86m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.017
Gross Margin83.51%
Net Profit Margin19.44%
Debt/Equity Ratio26.5%

How did 690 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 09:25
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Uni-Bio Science Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.